Overview

A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants

Status:
Not yet recruiting

Trial end date:
2023-02-13

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the relative bioavailability of alprazolam in plasma following a single dose of Staccato alprazolam compared to a single dose of oral alprazolam under fasted conditions

Phase:

Phase 1

Details

Lead Sponsor:

UCB Biopharma SRL

Treatments:

Alprazolam